(196 days)
The Sterile Disposable Syringe with Safety Needle is intended for use in the aspiration of fluids for medical purpose. After withdrawal of the needle from the body, the attached needle safety shield can be manually activated to cover the needle immediately after use to minimize risk of accidental needle sticks.
The Sterile Disposable Syringe with Needle is intended for use in the aspiration of fluids for medical purpose.
The Sterile Disposable Syringe is a sterile luer slip or luer lock syringe which is intended to be used with a hypodermic needle for the aspiration and injection of fluids for medical purpose.
The Sterile Disposable Safety Needle is intended to be used with a luer slip or lock syringe for aspiration and injection of fluids for medical purpose. After withdrawal of the needle from the body, the attached needle safety shield can be manually activated to cover the needle immediately after use to minimize risk of accidental needle sticks.
The Sterile Disposable Needle is intended to be used with a luer lock syringe for aspiration and injection of fluids for medical purpose.
The Sterile Disposable Syringe is intended for manual and single use only, which consists of piston, barrel, and plunger. The proposed device is available in a variety syringe volume. The syringe is available in luer lock and luer slip configurations, which are intended to be connected with a hypodermic needle.
The Sterile Disposable Safety Needle is intended for manual and single use only to aspirate and inject of fluids for medical purpose, which consists of needle tube, needle hub and safety mechanism. The proposed device is available in variety of needle length. The proposed device is compatible for use with a luer slip or luer lock syringe. After withdrawal of the needle from the body, the attached needle safety mechanism can be manually activated to cover the needle immediately after use to minimize risk of accidental needlesticks.
Compared with The Sterile Disposable Safety Needle, The Sterile Disposable Needle has the same components and specifications except without safety mechanism.
The Sterile Disposable Syringe with Safety Needle for Single Use is intended for manual and single use only to aspirate and inject of fluids for medical purpose, which consists of syringe (piston, barrel, plunger) and hypodermic needle with a safety mechanism. The proposed device is available in a variety combination of syringe volume and needle size.
Compared with The Sterile Disposable Syringe with Safety Needle, The Sterile Disposable Syringe with Needle has the same components and specifications except without safety mechanism.
The proposed devices are sterilized by Ethylene Oxide a SAL of 10-6 and supplied sterility maintenance package which could maintain the sterility of the device during the shelf life of 5 years.
The provided text describes a 510(k) premarket notification for several sterile disposable syringe and needle devices, comparing them to a predicate device (K193526). This submission focuses on establishing substantial equivalence through non-clinical testing and comparison of characteristics, rather than a clinical study evaluating diagnostic performance. Therefore, many of the requested elements for acceptance criteria and study design (like ground truth, expert qualifications, effect size for AI assistance, MRMC studies, and training set details) are not applicable to this type of submission.
The acceptance criteria for each device are defined by their compliance with relevant international and national standards, and the non-clinical tests performed to verify these compliances. The "reported device performance" is essentially that the devices met these acceptance criteria as demonstrated by the test results.
Here's a breakdown of the requested information based on the provided document:
Acceptance Criteria and Reported Device Performance
The acceptance criteria for the devices are primarily established by the relevant ISO and ASTM standards. The reported device performance is that it met the requirements of these standards.
Table of Acceptance Criteria and Reported Device Performance (Summary derived from Sections 6 and 8):
| Category / Item | Acceptance Criteria (Standard Reference) | Reported Device Performance |
|---|---|---|
| Biocompatibility | ISO 10993-5:2009 (Cytotoxicity), ISO 10993-10:2010 (Irritation/Sensitization), ISO 10993-11:2017 (Systemic Toxicity), ISO 10993-4:2017 (Blood Interaction) | No cytotoxicity, no intracutaneous reactivity, no sensitization, no systemic toxicity, no hemolysis, no pyrogen, no thrombogenicity, no complement activation potentials |
| Integrity of Sterile Barrier Packaging | ASTM F1886/F1886M-16 (Visual Inspection), ASTM F88/F88M-15 (Seal Strength), ASTM F1929-15 (Dye Penetration) | Maintained integrity |
| Sterilization | ISO 10993-7:2008 (EO and ECH Residuals), USP <85> (Bacterial Endotoxins) | EO/ECH residues did not exceed limit, Endotoxin limit did not exceed 20EU/device, maintained sterility for 5 years |
| Hypodermic Needles (General) | ISO 7864:2016 (Cleanliness, Acidity/Alkalinity, Extractable Metals, Size Designation, Color Coding, Needle Hub, Needle Cap, Needle Tube, Needle Point, Bond between Hub/Needle, Patency of Lumen) | Met requirements of related standards |
| Stainless Steel Needle Tubing | ISO 9626:2016 (Surface Finish/Appearance, Cleanliness, Acidity/Alkalinity, Size Designation, Dimensions, Stiffness, Resistance to Breakage/Corrosion) | Met requirements of related standards |
| Small-bore Connectors (Luer) | ISO 80369-7:2016 (Fluid Leakage, Sub-atmospheric Pressure Air Leakage, Stress Cracking, Resistance to Separation from Axial Load/Unscrewing, Resistance to Overriding) | Met requirements of related standards |
| Hypodermic Syringes (Manual Use) | ISO 7886-1:2017 (General requirements, Extraneous matter, Lubricant, Tolerance on Graduated Capacity, Graduated Scale, Barrel, Piston/Plunger Assembly, Nozzle, Performance) | Met requirements of related standards |
| Sharps Injury Protection (Safety Features) | ISO 23908:2011, FDA Guidance "Medical Device with Sharps Injury Prevention Feature" | Met pre-established criteria |
| Particulate Matter | USP <788> | Met requirements of related standards |
| Shelf-Life Evaluation | Physical, Mechanical, Chemical, Package Tests on aging samples | Device maintained performance during claimed 5-year shelf life |
2. Sample size used for the test set and the data provenance:
- Sample Size:
- For most non-clinical tests (biocompatibility, physical, mechanical, chemical, packaging, sterilization, shelf-life), specific sample sizes are not explicitly stated in the provided document. The document usually states "tests were performed" or "test results show."
- For the "Simulated Clinical Study" and "Safety Feature Test," the sample size is also not explicitly stated, only that "a simulated clinical study was performed" and "the safety feature test was performed on both proposed device and predicate device."
- Data Provenance: The document does not specify the country of origin for the test data. All studies described are non-clinical bench tests and simulated studies, not involving human subjects.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:
- This is not applicable as the evaluation relies entirely on non-clinical, bench testing against established international and national standards. There is no "ground truth" established by experts in the context of clinical interpretation, but rather adherence to engineering and material science specifications.
4. Adjudication method (e.g., 2+1, 3+1, none) for the test set:
- This is not applicable. Adjudication methods are typically used in clinical studies where expert consensus is needed to establish ground truth for subjective interpretations (e.g., image reading). The tests performed here are objective measurements against defined standards.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:
- This is not applicable. No MRMC study was conducted. This product is a physical medical device (syringes and needles), not an AI/software device intended for diagnostic assistance to human readers.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:
- This is not applicable. This product is a physical medical device, not an algorithm, so a standalone algorithm performance evaluation is not relevant.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.):
- The "ground truth" in this context is implicitly defined by the requirements and methodologies outlined in the referenced ISO and ASTM standards. For example, the "ground truth" for injectability might be defined by the force required to depress the plunger as per ISO 7886-1, or for biocompatibility, the absence of cytotoxicity as per ISO 10993-5. There is no clinical or expert consensus ground truth involved in this type of submission.
8. The sample size for the training set:
- This is not applicable. There is no "training set" as this is not a machine learning or AI device. The document describes pre-market non-clinical validation testing.
9. How the ground truth for the training set was established:
- This is not applicable for the reasons stated above.
{0}------------------------------------------------
Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services logo on the left and the FDA logo on the right. The FDA logo is a blue square with the letters "FDA" in white, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue.
November 15, 2021
Jiangsu Kangbao Medical Equipment Co., Ltd % Diana Hong General Manager Mid-Link Consulting Co., LTD. P.O. Box 120-119 Shanghai. 200120 China
Re: K211329
Trade/Device Name: Sterile Disposable Syringe with Saftey Needle, Sterile Disposable Syringe with Needle, Sterile Disposable Syringe, Sterile Disposable Safety Needle, Sterile Disposable Needle Regulation Number: 21 CFR 880.5860 Regulation Name: Piston Syringe Regulatory Class: Class II Product Code: MEG, FMF, FMI Dated: October 28, 2021 Received: October 29, 2021
Dear Diana Hong:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal
{1}------------------------------------------------
542 of the Act); 21 CFR 1000-1050.
statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
CAPT Alan Stevens Assistant Director DHT3C: Division of Drug Delivery and General Hospital Devices, and Human Factors OHT3: Office of GastroRenal, ObGyn, General Hospital and Urology Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration
Indications for Use
510(k) Number (if known) K211329
Device Name
Sterile Disposable Syringe with Safety Needle, Sterile Disposable Syringe with Needle, Sterile Disposable Syringe, Sterile Disposable Safety Needle, Sterile Disposable Needle
Indications for Use (Describe)
The Sterile Disposable Syringe with Safety Needle is intended for use in the aspiration of fluids for medical purpose. After withdrawal of the needle from the body, the attached needle safety shield can be manually activated to cover the needle immediately after use to minimize risk of accidental needle sticks.
The Sterile Disposable Syringe with Needle is intended for use in the aspiration of fluids for medical purpose.
The Sterile Disposable Syringe is a sterile luer slip or luer lock syringe which is intended to be used with a hypodermic needle for the aspiration and injection of fluids for medical purpose.
The Sterile Disposable Safety Needle is intended to be used with a luer slip or lock syringe for aspiration and injection of fluids for medical purpose. After withdrawal of the needle from the body, the attached needle safety shield can be manually activated to cover the needle immediately after use to minimize risk of accidental needle sticks.
The Sterile Disposable Needle is intended to be used with a luer lock syringe for aspiration and injection of fluids for medical purpose.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| Prescription Use (Part 21 CFR 801 Subpart D) | Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the
time to review instructions, search existing data sources, gather and maintain the data needed and complete
and review the collection of information. Send comments regarding this burden estimate or any other aspect
of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services
Food and Drug Administration
Office of Chief Information Officer
Paperwork Reduction Act (PRA) Staff
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of
information unless it displays a currently valid OMB number."
Form Approved: OMB No. 0910-0120
Expiration Date: 06/30/2023
See PRA Statement below.
{3}------------------------------------------------
510(k) Summary
This 510(k) Summary is being submitted in accordance with requirements of Title 21, CFR Section 807.92.
The assigned 510(k) Number: K211329
-
- Date of Preparation: 11/03/2021
-
- Sponsor Identification
Jiangsu Kangbao Medical Equipment Co., Ltd. 78#, North Suzhong Road Baoying 225800 Yangzhou PEOPLE'S REPUBLIC OF CHINA
Establishment Registration Number: 3009742443
Contact Person: Rujun Tang Position: Management Representative Tel: +86-514-88223540 Fax: +86-514-88232089 Email: 76823131@qq.com
- Designated Submission Correspondent 3.
Ms. Diana Hong (Primary Contact Person) Ms. Tingting Su (Alternative Contact Person)
Mid-Link Consulting Co., Ltd P.O. Box 120-119, Shanghai, 200120, China
Tel: +86-21-22815850, Fax: 360-925-3199 Email: info@mid-link.net
{4}------------------------------------------------
4. Identification of Proposed Device
Trade Name: Sterile Disposable Syringe with Safety Needle
Sterile Disposable Syringe with Needle Sterile Disposable Syringe Sterile Disposable Safety Needle Sterile Disposable Needle
Common Name: Syringes with Needle
Regulatory Information Classification Name: Syringe, Piston Classification: II; Product Code: FMF; Regulation Number: 21CFR 880.5860; Review Panel: General Hospital;
Classification Name: Needle, Hypodermic, Single Lumen Classification: II Product Code: FMI; Regulation Number: 21 CFR 880.5570 Review Panel: General Hospital;
Classification Name: Piston Syringe Classification: II; Product Code: MEG; Regulation Number: 21 CFR 880. 5860; Review Panel: General Hospital
Indications for use:
The Sterile Disposable Syringe with Safety Needle is intended for use in the aspiration and injection of fluids for medical purpose. After withdrawal of the needle from the body, the attached needle safety shield can be manually activated to cover the needle immediately after use to minimize risk of accidental needle sticks.
The Sterile Disposable Syringe with Needle is intended for use in the aspiration and injection of fluids for medical purpose.
The Sterile Disposable Syringe is a sterile luer slip or luer lock syringe which is intended to be used with a hypodermic needle for the aspiration and injection of fluids for medical purpose.
{5}------------------------------------------------
The Sterile Disposable Safety Needle is intended to be used with a luer slip or luer lock syringe for aspiration and injection of fluids for medical purpose. After withdrawal of the needle from the body, the attached needle safety shield can be manually activated to cover the needle immediately after use to minimize risk of accidental needle sticks.
The Sterile Disposable Needle is intended to be used with a luer slip or luer lock syringe for aspiration and injection of fluids for medical purpose.
Device Description
The Sterile Disposable Syringe is intended for manual and single use only, which consists of piston, barrel, and plunger. The proposed device is available in a variety syringe volume. The syringe is available in luer lock and luer slip configurations, which are intended to be connected with a hypodermic needle.
Syringe volume: 1ml, 2ml, 3ml, 10ml, 20ml, 30ml, 50ml, 60ml
The Sterile Disposable Safety Needle is intended for manual and single use only to aspirate and inject of fluids for medical purpose, which consists of needle tube, needle hub and safety mechanism. The proposed device is available in variety of needle length. The proposed device is compatible for use with a luer slip or luer lock syringe. After withdrawal of the needle from the body, the attached needle safety mechanism can be manually activated to cover the needle immediately after use to minimize risk of accidental needlesticks. Needle specification is same as the needle size of The Sterile Disposable Syringe with Safety Needle.
Needle specification: 23G1/2", 23G5/8", 23G1", 23G1-1/4" and 23G*1-1/2"
Compared with The Sterile Disposable Safety Needle, The Sterile Disposable Needle has the same components and specifications except without safety mechanism.
The Sterile Disposable Syringe with Safety Needle for Single Use is intended for manual and single use only to aspirate and inject of fluids for medical purpose, which consists of syringe (piston, barrel, plunger) and hypodermic needle with a safety mechanism. The proposed device is available in a variety combination of syringe volume and needle size.
Compared with The Sterile Disposable Syringe with Safety Needle, The Sterile Disposable Syringe with Needle has the same components and specifications except without safety mechanism.
The proposed devices are sterilized by Ethylene Oxide a SAL of 106 and supplied sterility maintenance package which could maintain the sterility of the device during the shelf life of 5 years.
{6}------------------------------------------------
- న్. Identification of Predicate Device
510(k) Number: K193526 Product Name: Syringe with safety needle, Safety needle
6. Non-Clinical Test Conclusion
Nonclinical tests were conducted to verify that the proposed device met all design specifications as was Substantially Equivalent (SE) to the predicate device. The test results demonstrated that the proposed device complies with the following standards:
-
ISO 10993-5:2009 Biological evaluation of medical Devices-Part 5: Tests for in Vitro Cytotoxicity
-
ISO 10993-10:2010 Biological evaluation of medical devices- Part 10: Test for irritation and skin sensitization.
- A ISO 10993-11:2017 Biological evaluation of medical devices- Part 11: Tests for systemic toxicity
- A ISO 10993-4:2017 Biological Evaluation of Medical Devices-Part 4: Selection of Tests for Interactions with Blood
-
ASTM F756-17 Standard Practice for Assessment of Hemolytic Properties of Materials
-
ASTM F1886 / F1886M-16, Standard Test Method for Determining Integrity of Seals for Flexible Packaging by Visual Inspection
- A ASTM F88/F88M-15, Standard Test Method for Seal Strength of Flexible Barrier Materials. (Sterility)
-
ASTM F1929-15 Standard Test Method for Detecting Seal Leaks in Porous Medical Package by Dye Penetration
-
ISO 7864:2016 Sterile hypodermic needles for single use - Requirements and test methods
-
ISO 9626:2016, Stainless Steel Needle Tubing For The Manufacture of Medical Devices
- ISO 6009:2016 Hypodermic needles for single use Colour coding for identification A
-
ISO 80369-7:2016 Small-bore connectors for liquids and gases in healthcare applications - Part 7: Connectors for intravascular or hypodermic applications
-
ISO 7886-1:2017 Sterile hypodermic syringes for single use- Part 1: Syringes for manual use.
-
ISO 10993-7:2008 Biological Evaluation of Medical Device-Part 7: Ethylene Oxide Sterilization Residuals
-
ISO 23908:2011 Sharps injury protection - Requirements and test methods - Sharps protection features for single-use hypodermic needles, introducers for catheters and needles used for blood sampling
-
USP<85> Bacterial Endotoxins Test
- A USP<151> Pyrogen Test
-
USP<788> Particulate Matter in Injections
{7}------------------------------------------------
Physical, Mechanical, Chemical testing listed in following table were performed on the proposed device. The test results show that the device meets the requirements of related standards.
| Item | Standard |
|---|---|
| Cleanliness | Clause 4.3 of ISO 7864:2016 |
| Limits for acidity or alkalinity | Clause 4.4 of ISO 7864:2016 |
| Limits for extractable metals | Clause 4.5 of ISO 7864:2016 |
| Size designation | Clause 4.6 of ISO 7864:2016 |
| Color coding | Clause 4.7 of ISO 7864:2016 |
| Needle hub | Clause 4.8 of ISO 7864:2016 |
| Needle Cap | Clause 4.9 of ISO 7864:2016 |
| Needle tube | Clause 4.10 of ISO 7864:2016 |
| Needle point | Clause 4.11 of ISO 7864:2016 |
| Bond between hub and needle tube | Clause 4.12 of ISO 7864:2016 |
| Patency of lumen | Clause 4.13 of ISO 7864:2016 |
| Item | Standard |
|---|---|
| Surface finish and appearance | Clause 5.2 of ISO 9626:2016 |
| Cleanliness | Clause 5.3 of ISO 9626:2016 |
| Limits for acidity and alkalinity | Clause 5.4 of ISO 9626:2016 |
| Size designation | Clause 5.5 of ISO 9626:2016 |
| Dimensions | Clause 5.6 of ISO 9626:2016 |
| Stiffness | Clause 5.8 of ISO 9626:2016 |
| Resistance to breakage | Clause 5.9 of ISO 9626:2016 |
| Resistance to corrosion | Clause 5.10 of ISO 9626:2016 |
| Item | Standard |
|---|---|
| Fluid leakage | Clause 6.1 of ISO 80369-7:2016 |
| Sub-atmospheric pressure air leakage | Clause 6.2 of ISO 80369-7:2016 |
| Stress cracking | Clause 6.3 of ISO 80369-7:2016 |
| Resistance to separation form axial load | Clause 6.4 of ISO 80369-7:2016 |
| Resistance to separation form unscrewing | Clause 6.5 of ISO 80369-7:2016 |
| Resistance to overriding | Clause 6.6 of ISO 80369-7:2016 |
General requirements
Clause 5 of ISO 7886-1:2017
{8}------------------------------------------------
| Extraneous matter | Clause 6 of ISO 7886-1:2017 |
|---|---|
| Lubricant | Clause 7 of ISO 7886-1:2017 |
| Tolerance on graduated capacity | Clause 8 of ISO 7886-1:2017 |
| Graduated scale | Clause 9 of ISO 7886-1:2017 |
| Barrel | Clause 10 of ISO 7886-1:2017 |
| Piston/ plunger assembly | Clause 11 of ISO 7886-1:2017 |
| Nozzle | Clause 12 of ISO 7886-1:2017 |
| Performance | Clause 13 of ISO 7886-1:2017 |
| Particulate testing | USP <788> |
Sterile barrier packaging testing were performed on the proposed device, which include visual inspection (ASTM F1886/F1886M-16), seal strength (ASTM F88/F88-15) and dye penetration test (ASTM F1929-15). The test result showed that the device package can maintain its integrity.
Sterilization and shelf-life testing listed in following table were performed on the proposed device. EO ECH residue did not exceed the limit of ISO 10993-7. Endotoxin limit did not exceed 20EU/device. Shelf-life test result showed that the device can maintain its performance during the claimed shelf life.
| Item | Standard |
|---|---|
| EO residue | ISO 10993-7:2008 |
| ECH residue | ISO 10993-7:2008 |
| Bacteria Endotoxin Limit | USP <85> |
| Shelf-Life Evaluation | Physical, Mechanical, Chemical, Package Testswere performed on aging samples to verify theclaimed shelf life of the device |
Biocompatibility testing
The contact level of the proposed device is blood path, indirect, and the contact duration is limited contact (<24 hours). The proposed device was evaluated for the following tests. The results for the biocompatibility testing showed that there are no negative impacts from the materials that are used in the proposed device.
-
Cytotoxicity,
-
Sensitization,
-
Intracutaneous,
-
Acute Systemic Toxicity,
-
Hemolysis,
- A Pyrogen,
{9}------------------------------------------------
- ア In vivo thromboresistance,
-
Complement activation.
Simulated Clinical Study
A simulated clinical study was performed on proposed device according to FDA Guidance, Guidance for Industry and FDA Staff: Medical Device with Sharps Injury Prevention Feature, issued on August 9, 2005 and ISO 23908:2011 to evaluate the safety mechanism of the proposed device. The results demonstrated that the proposed device met the pre-established criteria.
Safety Feature Test
The safety feature test was performed on both proposed device and predicate device to determine its safety feature. The results demonstrated that both the test data of the proposed device is very close to the test data of the predicate device.
-
- Clinical Test Conclusion
No clinical study is included in this submission.
- Clinical Test Conclusion
{10}------------------------------------------------
8. Summary of Technology Characteristics
| ITEM | Proposed Device | Predicate Device | Remark | |
|---|---|---|---|---|
| Product | Sterile Disposable Syringe with Safety Needle | Syringe with Safety Needle | / | |
| Product Code | FMFFMIMEG | FMFFMIMEG | SE | |
| Regulation Number | 21 CRF 880.586021 CRF 880.5570 | 21 CRF 880.586021 CRF 880.5570 | SE | |
| Class | Class II | Class II | SE | |
| Indication for Use | The Sterile Disposable Syringe with Safety Needle is intended for use in the aspiration and injection of fluids for medical purpose. After withdrawal of the needle from the body, the attached needle safety shield can be manually activated to cover the needle immediately after use to minimize risk of accidental needle sticks. | The Syringe with Safety Needle is intended for use in the aspiration and injection of fluids for medical purpose. After withdrawal of the needle from the body, the attached needle safety shield can be manually activated to cover the needle immediately after use to minimize risk of accidental needle stick. | SE | |
| Configuration | Syringe | SyringeBarrel (luer lock) | Analysis 1 | |
| Barrel (luer lock/luer slip)PlungerPistonNeedleNeedle hubNeedle tubeNeedle capSafety mechanism | PlungerPistonNeedle hubNeedle tubeNeedle capSafety shield | |||
| Operation Mode | For manual use only | For manual use only | SE | |
| Sterilized | Yes | Yes | SE | |
| Single Use | Single Use | Single Use | SE | |
| Label/Labeling | Complied with 21 CFR part 801 | Complied with 21 CFR part 801 | SE | |
| Syringe Volume | 1ml 2ml 3ml 5ml 10ml | 1ml 3ml 5ml 10ml 20ml 30ml | Analysis 2 | |
| 20ml, 30ml, 50ml, 60ml | 60ml | |||
| ConnectorType | Luer Lock and Luer Slip | Luer Lock | Analysis 1 | |
| Needle | Size | 23G | 16G,18G, 19G, 20G, 21G, 22G,23G, 25G, 26G, 27G, 28G, 29G,30G, 31G | Analysis 3 |
| Length | 1/2", 5/8", 3/4", 1", 1-1/4",1-1/2" | 13mm(1/2"), 16mm(5/8"),20mm(3/4"), 25mm(1"),32mm(1-1/4"), 38mm(1-1/2") | SE | |
| Syringe Performance | Complied withISO 7886-1 | Complied withISO 7886-1 | SE | |
| Needle Performance | Complied withISO 7864,ISO 9626 | Complied withISO 7864,ISO 9626 | SE | |
| Luer | ConnectorPerformance | Complied withISO 80369-7 | Complied withISO 80369-7 | SE |
| Patient-contact Materials | ||||
| Barrel | Polypropylene (PP) | Polypropylene (PP) | Analysis 4 | |
| Plunger | Polypropylene (PP) | Polypropylene (PP) | ||
| Piston | Polyisoprene Rubber | Polyisoprene | ||
| Needle hub | Polypropylene (PP) and bluepigment | Polypropylene (PP) | ||
| Needle tube | Stainless Steel SUS 304 | Stainless Steel 304 | ||
| Needle cap | Polypropylene (PP) | Polypropylene (PP) | ||
| Safety mechanism | Polypropylene (PP) and bluepigment | Polypropylene (PP) | ||
| Lubricants | Silicone oil | Polydimethylsiloxane | ||
| Adhesive | UV adhesive | Epoxy adhesive | ||
| Biocompatibility | ||||
| Cytotoxicity | No cytotoxicity | Conforms to ISO 10993 seriesstandards | SE | |
| Irritation | No intracutaneous reactivity | |||
| Sensitization | No sensitization | |||
| Systemic Toxicity | No systemic toxicity | |||
| Hemolysis | No Hemolysis | |||
| Pyrogen | No Pyrogen | |||
| ComplementActivation | Not show potentials toactivate complete system | |||
| In vivoThrombogenicity | No thrombogenicity | |||
| Sterilization | ||||
| Method | EO Sterilized | EO Sterilized | SE | |
| SAL | $10^{-6}$ | $10^{-6}$ | SE | |
| Endotoxin Limit | 20 EU per device | 20 EU per device | SE | |
| ITEM | Proposed Device | Predicate Device | Remark | |
| Product | Sterile Disposable Syringe with Needle | Sterile Disposable Syringe with Safety Needle | / | |
| Product Code | FMFFMI | FMFFMIMEG | Analysis 5 | |
| Regulation Number | 21 CRF 880.586021 CRF 880.5570 | 21 CRF 880.586021 CRF 880.5570 | Analysis 5 | |
| Class | Class II | Class II | SE | |
| Indication for Use | The Sterile Disposable Syringe with Needle is intended for use in the aspiration and injection of fluids for medical purpose. | The Syringe with Safety Needle is intended for use in the aspiration and injection of fluids for medical purpose. After withdrawal of the needle from the body, the attached needle safety shield can be manually activated to cover the needle immediately after use to minimize risk of accidental needle stick. | Analysis 6 | |
| Configuration | SyringeBarrel (luer lock/luer slip)PlungerPistonNeedleNeedle hubNeedle tubeNeedle cap/ | SyringeBarrel (luer lockPlungerPistonNeedleNeedle hubNeedle tubeNeedle capSafety Shield | Analysis 7 | |
| Operation Mode | For manual use only | For manual use only | SE | |
| Sterilized | Yes | Yes | SE | |
| Single Use | Single Use | Single Use | SE | |
| Label/Labeling | Complied with 21 CFR part 801 | Complied with 21 CFR part 801 | SE | |
| Syringe Volume | 1ml, 2ml, 3ml, 5ml, 10ml, 20ml, 30ml, 50ml, 60ml | 1ml, 3ml, 5ml, 10ml, 20ml, 30ml, 60ml | Analysis 8 | |
| Connector Type | Luer Lock and Luer Slip | Luer Lock | Analysis 7 | |
| Needle Size | 23G | 16G, 18G, 19G, 20G, 21G, 22G, 23G, 25G, 26G, 27G, 28G, 29G | Analysis 9 | |
| 30G, 31G | ||||
| Length | 1/2", 5/8", 3/4", 1", 1-1/4",1-1/2" | 13mm(1/2"),20mm(3/4"),32mm(1-1/4"), 38mm(1-1/2") | 16mm(5/8"),25mm(1"),SE | |
| Syringe Performance | Complied withISO 7886-1 | Complied withISO 7886-1 | SE | |
| Needle Performance | Complied withISO 7864,ISO 9626 | Complied withISO 7864,ISO 9626 | SE | |
| Luer ConnectorPerformance | Complied withISO 80369-7 | Complied withISO 80369-7 | SE | |
| Patient-contact Materials | ||||
| Barrel | Polypropylene (PP) | Polypropylene (PP) | Analysis | |
| Plunger | Polypropylene (PP) | Polypropylene (PP) | 10 | |
| Piston | Polyisoprene Rubber | Polyisoprene | ||
| Needle hub | Polypropylene (PP) and bluepigment | Polypropylene (PP) | ||
| Needle tube | Stainless Steel SUS 304 | Stainless Steel 304 | ||
| Needle cap | Polypropylene (PP) | Polypropylene (PP) | ||
| Lubricants | Silicone oil | Polydimethylsiloxane | ||
| Adhesive | UV adhesive | Epoxy adhesive | ||
| Biocompatibility | ||||
| Cytotoxicity | No cytotoxicity | Conforms to ISO 10993 seriesstandards | SE | |
| Irritation | No intracutaneous reactivity | |||
| Sensitization | No sensitization | |||
| Systemic Toxicity | No systemic toxicity | |||
| Hemolysis | No Hemolysis | |||
| Pyrogen | No Pyrogen | |||
| Complement Activation | Not show potentials to activatecomplete system | |||
| In Thrombogenicity | vivo | No thrombogenicity | ||
| Sterilization | ||||
| Method | EO Sterilized | EO Sterilized | SE | |
| SAL | 10-6 | 10-6 | SE | |
| Endotoxin Limit | 20 EU per device | 20 EU per device | SE |
Table 1. Comparison of Sterile Disposable Syringe with Safety Needle
{11}------------------------------------------------
{12}------------------------------------------------
Analysis 1- Configuration
The configuration of the proposed device is similar to the predicate device. The predicate device has luer lock connector, the proposed device has luer lock or luer slip connector. The difference in technological characteristics does not raise new questions of safety and effectiveness. Connectivity to the needle is assessed with performance data.
Analysis 2-Syringe Volume
The syringe volume for proposed device is different from the predicate devices. However, this difference is in dimension. Different volume device will be selected by physician per patient's condition. Therefore, this difference will not raise new questions on safety and effectiveness of the proposed device. Differences are assessed via performance data and conformance to the same ISO standards as the predicate device.
Analysis 3-Needle Size
The needle size for proposed device is different from the predicate devices. This difference is in dimension. Different size device will be selected by physician per patient's condition. Moreover, the needle size of the proposed syringe with safety needle is included in the range of the needle size of the predicate device. Therefore, this difference will not raise new questions on safety and effectiveness of the proposed device. Differences are assessed via performance data and conformance to the same ISO standards as the predicate device.
Analysis 4- Patient-contact Materials
Although the patient-contact material for proposed device is different from the predicate device. However, biocompatibility test has been performed on the proposed device and the results do not show any adverse effect. Therefore, this difference will not raise new questions on safety and effectiveness of the proposed device.
{13}------------------------------------------------
Table 2. Comparison of Sterile Disposable Syringe with Needle
{14}------------------------------------------------
Analysis 5-Product Code
The predicate device has a syringe with safety needle, so the corresponding product codes are MEG, FMF and FMI. The proposed syringe with needle consists of a syringe and needle, so the 12 / 22
{15}------------------------------------------------
corresponding product codes is FMF and FMI. Because the proposed syringe with needle has no safety mechanism, there is no MEG code, the product codes of proposed products are included in the codes of predicate device.
Based on above analysis, the difference on product code will not raise new questions on safety and effectiveness of the proposed device.
Analysis 6-Indication for Use
The indication for use of the proposed device and the predicate device differs in the verbal descriptions, and the actual indication for use of both devices is exactly the same. Both devices are intended for use in the aspiration and injection of fluids for medical purpose. The main difference in the indication for use is that there is no safety mechanism for the syringe with the needle, whether there is a safety mechanism or not will not affect the intended use of the equipment itself. Therefore, this difference will not raise new questions on safety and effectiveness of the proposed device.
Analysis 7- Configuration
The configuration of the proposed device is similar to the predicate device. The predicate device has luer lock connector, the proposed device has luer lock or luer slip connector. The difference in technological characteristics does not raise new questions of safety and effectiveness. Connectivity to the needle is assessed with performance data.
Analysis 8-Syringe Volume
The Syringe volume for the proposed device is different from the predicate devices. However, this difference is in dimension. Different volume device will be selected by physician per patient's condition. Therefore, this difference will not raise new questions on safety and effectiveness of the proposed device, Differences are assessed via performance data and conformance to the same ISO standards as the predicate device.
Analysis 9-Needle Size
The needle size for proposed device is different from the predicate devices. This difference is in dimension. Different size device will be selected by physician per patient's condition. Moreover, the needle size of the proposed syringe with needle is included in the range of the needle size of the predicate device. Therefore, this difference will not raise new questions on safety and effectiveness of the proposed device. Differences are assessed via performance data and conformance to the same ISO standards as the predicate device.
Analysis 10- Patient-contact Materials
Although the patient-contact material for proposed device is different from the predicate device. However, biocompatibility test has been performed on the proposed device and the results do not show any adverse effect. Therefore, this difference will not raise new questions on safety and effectiveness of the proposed
{16}------------------------------------------------
device.
{17}------------------------------------------------
| ITEM | Proposed Device | Predicate DeviceK193526 | Remark | |
|---|---|---|---|---|
| Product | Disposable Sterile Syringe | Syringe with Safety Needle | / | |
| Product Code | FMF | FMFFMIMEG | Analysis 11 | |
| Regulation Number | 21 CRF 880.5860 | 21 CRF 880.586021 CRF 880.5570 | Analysis 11 | |
| Class | Class II | Class II | SE | |
| Indication for Use | The Disposable Sterile Syringeis a sterile luer lock syringewhich is intended to be usedwith a hypodermic needle forthe aspiration and injection offluids for medical purpose. | The Syringe with Safety Needleis intended for use in theaspiration and injection offluids for medical purpose.After withdrawal of the needlefrom the body, the attachedneedle safety shield can bemanually activated to cover theneedle immediately after use tominimize risk of accidentalneedle stick. | Analysis 12 | |
| Configuration | Barrel (luer lock/luer slip)PlungerPiston | Barrel (luer lock)PlungerPiston | Analysis 13 | |
| Operation Mode | For manual use only | For manual use only | SE | |
| Sterilized | Yes | Yes | SE | |
| Single Use | Single Use | Single Use | SE | |
| Label/Labeling | Complied with 21 CFR part 801 | Complied with 21 CFR part 801 | SE | |
| Syringe | Volume | 1ml, 2ml, 3ml, 5ml, 10ml,20ml, 30ml, 50ml, 60ml | 1ml, 3ml, 5ml, 10ml, 20ml,30ml, 60ml | Analysis 14 |
| Connector Type | Luer Lock and Luer Slip | Luer Lock | Analysis 13 | |
| Syringe Performance | Complied withISO 7886-1 | Complied withISO 7886-1 | SE | |
| Luer | Connector Performance | Complied withISO 80369-7 | Complied withISO 80369-7 | SE |
| Patient-contact Materials | ||||
| Barrel | Polypropylene (PP) | Polypropylene (PP) | Analysis 15 | |
| Plunger | Polypropylene (PP) | Polypropylene (PP) | ||
| Piston | Polyisoprene Rubber | Polyisoprene | ||
| Lubricants | Silicone oil | Polydimethylsiloxane | ||
| Biocompatibility | ||||
| Cytotoxicity | No cytotoxicity | Conforms to ISO 10993 series standards | SE | |
| Irritation | No intracutaneous reactivity | |||
| Sensitization | No sensitization | |||
| Systemic Toxicity | No systemic toxicity | |||
| Hemolysis | No Hemolysis | |||
| Pyrogen | No Pyrogen | |||
| Complement Activation | Not show potentials to activate complete system | |||
| In vivo Thrombogenicity | No thrombogenicity | |||
| Sterilization | ||||
| Method | EO Sterilized | EO Sterilized | SE | |
| SAL | 10-6 | 10-6 | SE | |
| Endotoxin Limit | 20 EU per device | 20 EU per device | SE |
Table 3. Comparison of Sterile Disposable Syringe
{18}------------------------------------------------
Analysis 11-Product Code
In the submission, the predicate device has syringe with safety needle and safety needle, so the corresponding product codes are MEG, FMF and FMI. The propose syringe consisting of barrel, piston, and plunger, so the corresponding product codes is FMF. Different product codes are caused by different applied products, but the product codes of applied products are included in the codes of predicate device.
Based on above analysis, the difference on product code will not raise new questions on safety and effectiveness of the proposed device.
Analysis 12-Indication for Use
The indication for use of the proposed device and the predicate device differs only in the verbal descriptions, and the actual indication for use of both devices is exactly the same. Both devices are intended for use in the aspiration and injection of fluids for medical purpose. Only the proposed syringe needs to be connected with the needle in order to fully achieve the intended use of aspiration and injection of liquid medicine. Therefore, this difference will not raise new questions on safety and effectiveness of the proposed device.
Analysis 13- Configuration
The configuration of the proposed device is similar to the predicate device. The predicate device has luer lock connector, the proposed device has luer lock or luer slip connector. The difference in technological characteristics does not raise new questions of safety and effectiveness. Connectivity to the needle is assessed with performance data.
{19}------------------------------------------------
Analysis 14-Syringe Volume
The Syringe volume for proposed device is different from the predicate devices. However, this difference is in dimension. Different volume device will be selected by physician per patient's condition. Therefore, this difference will not raise new questions on safety and effectiveness of the proposed device. Differences are assessed via performance data and conformance to the same ISO standards as the predicate device.
Analysis 15- Patient-contact Materials
Although the patient-contact material for proposed device is different from the predicate device. However, biocompatibility test has been performed on the proposed device and the results do not show any adverse effect. Therefore, this difference will not raise new questions on safety and effectiveness of the proposed device.
{20}------------------------------------------------
| ITEM | Proposed Device | Predicate Device K193526 | Remark | |
|---|---|---|---|---|
| Product | Sterile Disposable Safety Needle | Safety Needle | / | |
| Product Code | FMI | FMI | SE | |
| Regulation Number | 21 CRF 880.5860 | 21 CRF 880.5860 | SE | |
| Class | Class II | Class II | SE | |
| Indication for Use | The Sterile Disposable Syringe with Safety Needle is intended for use in the aspiration and injection of fluids for medical purpose. After withdrawal of the needle from the body, the attached needle safety shield can be manually activated to cover the needle immediately after use to minimize risk of accidental needle sticks. | The Safety Needle is intended for use with luer lock syringe for aspiration and injection of fluids for medical purpose. After withdrawal of the needle from the body, the attached needle safety shield can be manually activated to cover the needle immediately after use to minimize risk of accidental needle stick. | SE | |
| Configuration | Needle hub | Needle hub | SE | |
| Needle tube | Needle tube | |||
| Needle cap | Needle cap | |||
| Safety mechanism | Safety shield | |||
| Operation Mode | For manual use only | For manual use only | SE | |
| Sterilized | Yes | Yes | SE | |
| Single Use | Single Use | Single Use | SE | |
| Label/Labeling | Complied with 21 CFR part 801 | Complied with 21 CFR part 801 | SE | |
| Needle | Size | 23G | 16G, 18G, 19G, 20G, 21G, 22G, 23G, 25G, 26G, 27G, 28G, 29G, 30G, 31G | Analysis 16 |
| Length | 1/2", 5/8", 3/4", 1", 1-1/4", 1-1/2" | 13mm(1/2"), 16mm(5/8"), 20mm(3/4"), 25mm(1"), 32mm(1-1/4"), 38mm(1-1/2") | SE | |
| Needle | Performance | Complied withISO 7864,ISO 9626 | Complied withISO 7864,ISO 9626 | SE |
| Patient-contact Materials | ||||
| Needle hub | Polypropylene (PP) and blue pigment | Polypropylene (PP) | Analysis 17 | |
| Needle tube | Stainless Steel SUS 304 | Stainless Steel SUS 304 | ||
| Needle cap | Polypropylene (PP) | Polypropylene (PP) | ||
| Safety mechanism | Polypropylene (PP) and blue | Polypropylene (PP) | ||
| pigment | ||||
| Lubricants | Silicone oil | Polydimethylsiloxane | ||
| Adhesive | UV adhesive | Epoxy adhesive | ||
| Biocompatibility | ||||
| Cytotoxicity | No cytotoxicity | Conforms to ISO 10993 series | SE | |
| Irritation | No intracutaneous reactivity | standards | SE | |
| Sensitization | No sensitization | |||
| Systemic Toxicity | No systemic toxicity | |||
| Hemolysis | No Hemolysis | |||
| Pyrogen | No Pyrogen | |||
| ComplementActivation | Not show potentials to activatecomplete system | |||
| InvivoThrombogenicity | No thrombogenicity | |||
| Sterilization | ||||
| Method | EO Sterilized | EO Sterilized | SE | |
| SAL | 10-6 | 10-6 | SE | |
| Endotoxin Limit | 20 EU per device | 20 EU per device | SE | |
| ITEM | Proposed Device | Predicate Device K193526 | Remark | |
| Product | Sterile Disposable Needle | Safety Needle | / | |
| Product Code | FMI | FMI | SE | |
| RegulationNumber | 21 CRF 880.5860 | 21 CRF 880.5860 | SE | |
| Class | Class II | Class II | SE | |
| Indication for Use | The Sterile Disposable Needle isintended to be used with a luer slipor luer lock syringe for aspirationand injection of fluids for medicalpurpose. | The Safety Needle is intended foruse with luer lock syringe foraspiration and injection of fluidsfor medical purpose. Afterwithdrawal of the needle from thebody, the attached needle safetyshield can be manually activatedto cover the needle immediatelyafter use to minimize risk ofaccidental needle stick. | Analysis 18 | |
| Configuration | Needle hub | Needle hub | Analysis 19 | |
| Needle tube | Needle tube | |||
| Needle cap | Needle cap | |||
| / | Safety shield | |||
| Operation Mode | For manual use only | For manual use only | SE | |
| Sterilized | Yes | Yes | SE | |
| Single Use | Single Use | Single Use | SE | |
| Label/Labeling | Complied with 21 CFR part 801 | Complied with 21 CFR part 801 | SE | |
| Needle | Size | 23G | 16G, 18G, 19G, 20G, 21G, 22G,23G, 25G, 26G, 27G, 28G, 29G,30G, 31G | Analysis 20 |
| Length | 1/2", 5/8", 3/4", 1", 1-1/4", 1-1/2" | 13mm(1/2"), 16mm(5/8"),20mm(3/4"), 25mm(1"),32mm(1-1/4"), 38mm(1-1/2") | SE | |
| NeedlePerformance | Complied withISO 7864,ISO 9626 | Complied withISO 7864,ISO 9626 | SE | |
| Patient-contact Materials | ||||
| Needle hub | Polypropylene (PP) blue pigment | Polypropylene (PP) | Analysis 21 | |
| Needle tube | Stainless Steel SUS 304 | Stainless Steel SUS 304 | ||
| Needle cap | Polypropylene (PP) | Polypropylene (PP) | ||
| Lubricants | Silicone oil | Polydimethylsiloxane | ||
| Adhesive | UV adhesive | Epoxy adhesive | ||
| Biocompatibility | ||||
| Cytotoxicity | No cytotoxicity | Conforms to ISO 10993 series | SE | |
| Irritation | No intracutaneous reactivity | standards | SE | |
| Sensitization | No sensitization | |||
| Systemic Toxicity | No systemic toxicity | |||
| Hemolysis | No Hemolysis | |||
| Pyrogen | No Pyrogen | |||
| Complement | Not show potentials to activate | |||
| Activation | complete system | |||
| Invivo | No thrombogenicity | |||
| Thrombogenicity | ||||
| Sterilization | ||||
| Method | EO Sterilized | EO Sterilized | SE | |
| SAL | 10-6 | 10-6 | SE | |
| Endotoxin Limit | 20 EU per device | 20 EU per device | SE |
Table 4. Comparison of Sterile Disposable Safety Needle
{21}------------------------------------------------
Analysis 16-Needle Size
The needle size for proposed device is different from the predicate devices. This difference is in dimension. Different size device will be selected by physician per patient's condition. Moreover, the needle size of the proposed syringe with safety needle is included in the range of the needle size of the predicate device. Therefore, this difference will not raise new questions on safety and effectiveness of the proposed device. Differences are assessed via performance data and conformance to the same ISO standards as the predicate device.
Analysis 17- Patient-contact Materials
Although the patient-contact material for proposed device is different from the predicate device. However, biocompatibility test has been performed on the proposed device and the results do not show any adverse effect. Therefore, this difference will not raise new questions on safety and effectiveness of the proposed device.
{22}------------------------------------------------
Table 5. Comparison of Sterile Disposable Needle
{23}------------------------------------------------
Analysis 18-Indication for Use
The indication for use of the proposed device and the predicate device differs in the verbal descriptions, and the actual indication for use of both devices is exactly the same. Both devices are intended for use in the aspiration and injection of fluids for medical purpose. Whether there is a safety mechanism or not will not affect the intended use of the equipment itself. Therefore, this difference will not raise new questions on safety and effectiveness of the proposed device.
Analysis 19- Configuration
The configuration of proposed device is similar as the configurations of predicate device. Whether there is a safety mechanism or not will not affect the intended use of the equipment itself. Based on above analysis, the difference on configuration will not raise new questions on safety and effectiveness of the proposed device.
Analysis 20-Needle Size
The needle size for proposed device is different from the predicate devices. This difference is in dimension. Different size device will be selected by physician per patient's condition. Moreover, the needle size of the proposed syringe with safety needle is included in the range of the needle size of the predicate device. Therefore, this difference will not raise new questions on safety and effectiveness of the proposed device. Differences are assessed via performance data and conformance to the same ISO standards as the predicate device.
Analysis 21- Patient-contact Materials
{24}------------------------------------------------
Although the patient-contact material for proposed device is different from the predicate device. However, biocompatibility test has been performed on the proposed device and the results do not show any adverse effect. Therefore, this difference will not raise new questions on safety and effectiveness of the proposed device.
9. Conclusion
The conclusion drawn from the comparison to the predicate device and the non-clinical tests demonstrates that the subject device in 510(k) submission, The Sterile Disposable Syringe with Safety Needle, The Sterile Disposable Syringe with Needle, The Sterile Disposable Syringe, The Sterile Disposable Safety Needle and The Sterile Disposable Needle are substantially equivalent to the legally marketed predicate device cleared under K193526.
§ 880.5860 Piston syringe.
(a)
Identification. A piston syringe is a device intended for medical purposes that consists of a calibrated hollow barrel and a movable plunger. At one end of the barrel there is a male connector (nozzle) for fitting the female connector (hub) of a hypodermic single lumen needle. The device is used to inject fluids into, or withdraw fluids from, the body.(b)
Classification. Class II (performance standards).